TARGETING CLASS I PI3KS IN THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

$1,205,890FY2010Department of the ArmyDOD

The Trustees Of Columbia University In The City Of New York

Investigators